Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:44 p.m.

    📋 Orchestra Biomed Holdings Inc (OBIO) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 09:12:25

    Event Type: Clinical Trial Update

    Event Details:

    Orchestra Biomed Holdings Inc (OBIO) Announces Clinical Trial Update Orchestra Biomed Holdings Inc (OBIO) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: million, technology
    • Diseases/Conditions: a first milestone payment, percutaneous vessel closure
    • Collaboration: Orchestra BioMed Holdings, Inc.

    🔬 Clinical Development Pipeline (Orchestra Biomed Holdings Inc):

    Product Type Development Stage Therapeutic Area Source
    Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated DEVICE Approved Hypertension ClinicalTrials.gov
    AGENT™ Paclitaxel Drug-Coated Balloon DEVICE Approved Coronary Artery Disease ClinicalTrials.gov
    Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated DEVICE Approved Hypertension ClinicalTrials.gov
    Virtue Sirolimus AngioInfusion Balloon DEVICE Approved Coronary Artery Disease ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Orchestra Biomed Holdings Inc
    • Ticker Symbol: OBIO

Search

News categories